{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:27:50Z","timestamp":1794673670618,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12022-022-09703-7","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T07:02:58Z","timestamp":1647327778000},"page":"6-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":625,"title":["Overview of the 2022 WHO Classification of Pituitary Tumors"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-7261","authenticated-orcid":false,"given":"Arie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9126-8640","authenticated-orcid":false,"given":"Robert Y.","family":"Osamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"9703_CR1","doi-asserted-by":"crossref","DOI":"10.55418\/9781933477916","volume-title":"Tumors of the Pituitary Gland","author":"SL Asa","year":"2020","unstructured":"Asa, S. L. and Perry, A. (2020) Tumors of the Pituitary Gland. AFIP Atlas of Tumor and Non-Tumor Pathology, ARP Press, Arlington VA: ARP Press."},{"key":"9703_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00418-008-0472-1","volume":"130","author":"RY Osamura","year":"2008","unstructured":"Osamura RY, Kajiya H, Takei M, Egashira N, Tobita M, Takekoshi S, Teramoto A (2008) Pathology of the human pituitary adenomas. Histochem Cell Biol 130: 495-507. https:\/\/doi.org\/10.1007\/s00418-008-0472-1","journal-title":"Histochem Cell Biol"},{"key":"9703_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/PL00008197","volume":"436","author":"S Vidal","year":"2000","unstructured":"Vidal S, Horvath E, Kovacs K, Cohen SM, Lloyd RV, Scheithauer BW (2000) Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism. Virchows Arch 436: 43-51.","journal-title":"Virchows Arch"},{"key":"9703_CR4","first-page":"511","volume":"63","author":"E Horvath","year":"1990","unstructured":"Horvath E, Lloyd RV, Kovacs K (1990) Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 63: 511-520.","journal-title":"Lab Invest"},{"key":"9703_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-012-1266-3","volume":"461","author":"ME Jentoft","year":"2012","unstructured":"Jentoft ME, Osamura RY, Kovacs K, Lloyd RV, Scheithauer BW (2012) Transdifferentiation of pituitary thyrotrophs to lactothyrotrophs in primary hypothyroidism: case report. Virchows Arch 461: 221-225. https:\/\/doi.org\/10.1007\/s00428-012-1266-3","journal-title":"Virchows Arch"},{"issue":"9","key":"9703_CR6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"SL Asa","year":"2021","unstructured":"Asa S.L., Mete O, Cusimano MD, McCutcheon IE, Perry A et al. (2021) Pituitary Neuroendocrine Tumors: A Model for Neuroendocrine Tumor Classification. Mod Pathol. 34(9):1634-1650.","journal-title":"Mod Pathol"},{"key":"9703_CR7","doi-asserted-by":"publisher","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N, Korbonits M, Laws ER, Jr., Lopes MB, Maartens N, McCutcheon IE, Mete O, Nishioka H, Raverot G, Roncaroli F, Saeger W, Syro LV, Vasiljevic A, Villa C, Wierinckx A, Trouillas J (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24: C5-C8. 24\/4\/C5 https:\/\/doi.org\/10.1530\/ERC-17-0004","DOI":"10.1530\/ERC-17-0004"},{"key":"9703_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Kloppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31: 1770-1786. https:\/\/doi.org\/10.1038\/s41379-018-0110-y","journal-title":"Mod Pathol"},{"key":"9703_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.anndiagpath.2006.08.007","volume":"12","author":"MD Williams","year":"2008","unstructured":"Williams MD, Asa SL, Fuller GN (2008) Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol 12: 199-203.","journal-title":"Ann Diagn Pathol"},{"key":"9703_CR10","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2006-0610","volume":"91","author":"C Nasr","year":"2006","unstructured":"Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL (2006) Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab 91: 4776-4780.","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR11","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1210\/jcem.82.8.4175","volume":"82","author":"N Sanno","year":"1997","unstructured":"Sanno N, Teramoto A, Osamura RY, Genka S, Katakami H, Jin L, Lloyd RV, Kovacs K (1997) A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. J Clin Endocrinol Metab 82: 2731-2737. https:\/\/doi.org\/10.1210\/jcem.82.8.4175","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","volume":"31","author":"O Mete","year":"2020","unstructured":"Mete O, Asa SL (2020) Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors. Endocr Pathol 31: 330-336. https:\/\/doi.org\/10.1007\/s12022-020-09646-x","journal-title":"Endocr Pathol"},{"key":"9703_CR13","doi-asserted-by":"publisher","unstructured":"Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F, Ezzat S, Asa SL (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29: 131\u2013142. https:\/\/doi.org\/10.1038\/modpathol.2015.151","DOI":"10.1038\/modpathol.2015.151"},{"key":"9703_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00430697","volume":"387","author":"K Kovacs","year":"1980","unstructured":"Kovacs K, Horvath E, Ryan N, Ezrin C (1980) Null cell adenoma of the human pituitary. Virchows Arch [Pathol Anat ] 387: 165-174.","journal-title":"Virchows Arch [Pathol Anat ]"},{"key":"9703_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12022-018-9562-3","volume":"30","author":"KM Tordjman","year":"2019","unstructured":"Tordjman KM, Greenman Y, Ram Z, Hershkovitz D, Aizenstein O, Ariel O, Asa SL (2019) Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon. Endocr Pathol 30: 74-80. https:\/\/doi.org\/10.1007\/s12022-018-9562-3","journal-title":"Endocr Pathol"},{"key":"9703_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/01.MP.0000030451.28828.00","volume":"15","author":"S Tahara","year":"2002","unstructured":"Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Osamura RY (2002) A case of Cushing\u2019s disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol 15: 1102-1105. https:\/\/doi.org\/10.1097\/01.MP.0000030451.28828.00","journal-title":"Mod Pathol"},{"key":"9703_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12022-018-9545-4","volume":"29","author":"O Mete","year":"2018","unstructured":"Mete O, Alshaikh OM, Cintosun A, Ezzat S, Asa SL (2018) Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages. Endocr Pathol 29: 332-338. https:\/\/doi.org\/10.1007\/s12022-018-9545-4","journal-title":"Endocr Pathol"},{"key":"9703_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","volume":"32","author":"O Mete","year":"2019","unstructured":"Mete O, Kefeli M, Caliskan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32: 484-489. https:\/\/doi.org\/10.1038\/s41379-018-0167-7","journal-title":"Mod Pathol"},{"key":"9703_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I, Asa SL (2018) Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 31: 900-909. https:\/\/doi.org\/10.1038\/s41379-018-0016-8","journal-title":"Mod Pathol"},{"key":"9703_CR20","doi-asserted-by":"publisher","unstructured":"Asa SL, Mete O (2021) Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 107: 87\u201395. S0046\u20138177(20)30202\u20131 https:\/\/doi.org\/10.1016\/j.humpath.2020.10.004","DOI":"10.1016\/j.humpath.2020.10.004"},{"key":"9703_CR21","doi-asserted-by":"publisher","unstructured":"McDonald WC, McDonald KN, Helmer JA, Ho B, Wang A, Banerji N (2021) The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm. Arch Pathol Lab Med 145: 592\u2013598. 444337 https:\/\/doi.org\/10.5858\/arpa.2020-0091-OA","DOI":"10.5858\/arpa.2020-0091-OA"},{"key":"9703_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5858\/arpa.2016-0082-OA","volume":"141","author":"WC McDonald","year":"2017","unstructured":"McDonald WC, Banerji N, McDonald KN, Ho B, Macias V, Kajdacsy-Balla A (2017) Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma. Arch Pathol Lab Med 141: 104-112. https:\/\/doi.org\/10.5858\/arpa.2016-0082-OA","journal-title":"Arch Pathol Lab Med"},{"key":"9703_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1210\/jcem-66-6-1111","volume":"66","author":"E Horvath","year":"1988","unstructured":"Horvath E, Kovacs K, Smyth HS, Killinger DW, Scheithauer BW, Randall R, Laws ER, Jr., Singer W (1988) A novel type of pituitary adenoma: Morphological feature and clinical correlations. J Clin Endocrinol Metab 66: 1111-1118.","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/nan.12568","volume":"46","author":"E Manojlovic-Gacic","year":"2020","unstructured":"Manojlovic-Gacic E, Bollerslev J, Casar-Borota O (2020) Invited Review: Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint. Neuropathol Appl Neurobiol 46: 89-110. https:\/\/doi.org\/10.1111\/nan.12568","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9703_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12022-021-09678-x","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL (2021) Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors. Endocr Pathol 32: 222-227. https:\/\/doi.org\/10.1007\/s12022-021-09678-x","journal-title":"Endocr Pathol"},{"key":"9703_CR26","doi-asserted-by":"publisher","unstructured":"Asa SL, Kucharczyk W, Ezzat S (2017) Pituitary acromegaly: not one disease. Endocr Relat Cancer 24: C1-C4. ERC-16\u20130496 https:\/\/doi.org\/10.1530\/ERC-16-0496","DOI":"10.1530\/ERC-16-0496"},{"key":"9703_CR27","doi-asserted-by":"publisher","unstructured":"Asa SL, Ezzat S (2021) An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism. J Clin Med 10. https:\/\/doi.org\/10.3390\/jcm10112254","DOI":"10.3390\/jcm10112254"},{"key":"9703_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Ezzat S (2021) Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know? Endocr Pathol 32: 3-16. https:\/\/doi.org\/10.1007\/s12022-021-09663-4","journal-title":"Endocr Pathol"},{"key":"9703_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","volume":"19","author":"A Obari","year":"2008","unstructured":"Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur RM, Yamada S (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19: 82-91.","journal-title":"Endocr Pathol"},{"key":"9703_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/edrv-9-3-357","volume":"9","author":"T Sano","year":"1988","unstructured":"Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9: 357-373.","journal-title":"Endocr Rev"},{"key":"9703_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2265.2001.01268.x","volume":"55","author":"NH Othman","year":"2001","unstructured":"Othman NH, Ezzat S, Kovacs K, Horvath E, Poulin E, Smyth HS, Asa SL (2001) Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly. Clin Endocrinol (Oxf) 55: 135-140.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9703_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(19930101)71:1<66::AID-CNCR2820710112>3.0.CO;2-U","volume":"71","author":"S Ezzat","year":"1993","unstructured":"Ezzat S, Ezrin C, Yamashita S, Melmed S (1993) Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor. Cancer 71: 66-70.","journal-title":"Cancer"},{"key":"9703_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101: 613-619.","journal-title":"Cancer"},{"key":"9703_CR34","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82: 2102-2107.","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.580264","volume":"11","author":"P Luo","year":"2020","unstructured":"Luo P, Zhang L, Yang L, An Z, Tan H (2020) Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor. Front Endocrinol (Lausanne) 11: 580264. https:\/\/doi.org\/10.3389\/fendo.2020.580264","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9703_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.672178","volume":"12","author":"B Rak","year":"2021","unstructured":"Rak B, Maksymowicz M, Pekul M, Zielinski G (2021) Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing\u2019s Disease. Front Endocrinol (Lausanne) 12: 672178. https:\/\/doi.org\/10.3389\/fendo.2021.672178","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9703_CR37","first-page":"2291","volume":"83","author":"GL Booth","year":"1998","unstructured":"Booth GL, Redelmeier DA, Grosman H, Kovacs K, Smyth HS, Ezzat S (1998) Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing\u2019s disease. J Clin Endocrinol Metab 83: 2291-2295.","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.620005","volume":"12","author":"A Akirov","year":"2021","unstructured":"Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S (2021) Significance of Crooke\u2019s Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease. Front Endocrinol (Lausanne) 12: 620005. https:\/\/doi.org\/10.3389\/fendo.2021.620005","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9703_CR39","doi-asserted-by":"publisher","unstructured":"Graillon T, Castinetti F, Chabert-Orsini V, Morange I, Cuny T, Albarel F, Brue T, Dufour H (2019) Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature review. Ann Endocrinol (Paris) 80: 122\u2013127. S0003\u20134266(19)30025\u20133. https:\/\/doi.org\/10.1016\/j.ando.2018.11.007","DOI":"10.1016\/j.ando.2018.11.007"},{"key":"9703_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1227\/NEU.0000000000001188","volume":"79","author":"DJ Cote","year":"2016","unstructured":"Cote DJ, Smith TR, Sandler CN, Gupta T, Bale TA, Bi WL, Dunn IF, De GU, Woodmansee WW, Kaiser UB, Laws ER, Jr. (2016) Functional Gonadotroph Adenomas: Case Series and Report of Literature. Neurosurgery 79: 823-831. https:\/\/doi.org\/10.1227\/NEU.0000000000001188","journal-title":"Neurosurgery"},{"key":"9703_CR41","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1210\/jc.2014-2362","volume":"99","author":"G Ntali","year":"2014","unstructured":"Ntali G, Capatina C, Grossman A, Karavitaki N (2014) Clinical review: Functioning gonadotroph adenomas. J Clin Endocrinol Metab 99: 4423-4433. https:\/\/doi.org\/10.1210\/jc.2014-2362","journal-title":"J Clin Endocrinol Metab"},{"key":"9703_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S (2015) The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas. Endocr Pathol 26: 349-355. https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"key":"9703_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3171\/2012.1.PEDS11330","volume":"9","author":"M Yamaguchi-Okada","year":"2012","unstructured":"Yamaguchi-Okada M, Inoshita N, Nishioka H, Fukuhara N, Yamada S (2012) Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age. J Neurosurg Pediatr 9: 511-516. https:\/\/doi.org\/10.3171\/2012.1.PEDS11330","journal-title":"J Neurosurg Pediatr"},{"key":"9703_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1530\/EJE-20-1273","volume":"184","author":"NF Lenders","year":"2021","unstructured":"Lenders NF, Wilkinson AC, Wong SJ, Shein TT, Harvey RJ, Inder WJ, Earls PE, McCormack AI (2021) Transcription factor immunohistochemistry in the diagnosis of pituitary tumours. Eur J Endocrinol 184: 891-901. https:\/\/doi.org\/10.1530\/EJE-20-1273","journal-title":"Eur J Endocrinol"},{"key":"9703_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1385\/EP:16:3:187","volume":"16","author":"RA Jastania","year":"2005","unstructured":"Jastania RA, Alsaad KO, Al Shraim M, Kovacs K, Asa SL (2005) Double Adenomas of the Pituitary: Transcription Factors Pit-1, T-pit, and SF-1 Identify Cytogenesis and Differentiation. Endocr Pathol 16: 187-194.","journal-title":"Endocr Pathol"},{"key":"9703_CR46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s11102-016-0727-0","volume":"19","author":"S Roberts","year":"2016","unstructured":"Roberts S, Borges MT, Lillehei KO, Kleinschmidt-DeMasters BK (2016) Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up. Pituitary 19: 472-481. https:\/\/doi.org\/10.1007\/s11102-016-0727-0","journal-title":"Pituitary"},{"key":"9703_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-021-09671-4","author":"O Mete","year":"2021","unstructured":"Mete O, Ezzat S, Perry A, Yamada S, Uccella S, Grossman AB, Asa SL (2021) The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research. Endocr Pathol https:\/\/doi.org\/10.1007\/s12022-021-09671-4","journal-title":"Endocr Pathol"},{"key":"9703_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1586\/17446651.2016.1153422","volume":"11","author":"SL Asa","year":"2016","unstructured":"Asa SL, Ezzat S (2016) Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors. Expert Reviews Endocrinology and Metabolism 11: 149-162.","journal-title":"Expert Reviews Endocrinology and Metabolism"},{"key":"9703_CR49","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/modpathol.2011.119","volume":"24","author":"O Mete","year":"2011","unstructured":"Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24: 1545-1552.","journal-title":"Mod Pathol"},{"key":"9703_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000124545","volume":"43","author":"SL Asa","year":"1986","unstructured":"Asa SL, Kovacs K, Laszlo FA, Domokos I, Ezrin C (1986) Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology 43: 308-316.","journal-title":"Histologic and immunocytochemical analysis. Neuroendocrinology"},{"key":"9703_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000125044","volume":"48","author":"SL Asa","year":"1988","unstructured":"Asa SL, Kovacs K, Horvath E, Losinski NE, Laszlo FA, Domokos I, Halliday WC (1988) Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 48: 423-431.","journal-title":"Neuroendocrinology"},{"key":"9703_CR52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","volume":"15","author":"BW Scheithauer","year":"2012","unstructured":"Scheithauer BW, Horvath E, Abel TW, Robital Y, Park SH, Osamura RY, Deal C, Lloyd RV, Kovacs K (2012) Pituitary blastoma: a unique embryonal tumor. Pituitary 15: 365-373.","journal-title":"Pituitary"},{"key":"9703_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park SH, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, Perry A, Leichter H, Maeder P, Brundler MA, Warner J, Neal J, Zacharin M, Korbonits M, Cole T, Traunecker H, McLean TW, Rotondo F, Lepage P, Albrecht S, Horvath E, Kovacs K, Priest JR, Foulkes WD (2014) Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128: 111-122.","journal-title":"Acta Neuropathol"},{"key":"9703_CR54","doi-asserted-by":"publisher","unstructured":"Liu APY, Kelsey MM, Sabbaghian N, Park SH, Deal CL, Esbenshade AJ, Ploner O, Peet A, Traunecker H, Ahmed YHE, Zacharin M, Tiulpakov A, Lapshina AM, Walter AW, Dutta P, Rai A, Korbonits M, de KL, Nichols KE, Foulkes WD, Priest JR (2021) Clinical Outcomes and Complications of Pituitary Blastoma. J Clin Endocrinol Metab 106: 351\u2013363. 6000434 https:\/\/doi.org\/10.1210\/clinem\/dgaa857","DOI":"10.1210\/clinem\/dgaa857"},{"key":"9703_CR55","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/PAS.0b013e31829723e7","volume":"37","author":"O Mete","year":"2013","unstructured":"Mete O, Lopes MB, Asa SL (2013) Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 37: 1694-1699.","journal-title":"Am J Surg Pathol"},{"key":"9703_CR56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-021-02377-1","volume":"142","author":"S Schmid","year":"2021","unstructured":"Schmid S, Solomon DA, Perez E, Thieme A, Kleinschmidt-DeMasters BK, Giannini C, Reinhardt A, Asa SL, Mete O, Stichel D, Siewert C, Dittmayer C, Hasselblatt M, Paulus W, Nagel C, Harter PN, Schittenhelm J, Honegger J, Rushing E, Coras R, Pfister SM, Buslei R, Koch A, Perry A, Jones DTW, von DA, Capper D, Lopes MB (2021) Genetic and epigenetic characterization of posterior pituitary tumors. Acta Neuropathol 142: 1025-1043. https:\/\/doi.org\/10.1007\/s00401-021-02377-1","journal-title":"Acta Neuropathol"},{"key":"9703_CR57","doi-asserted-by":"publisher","unstructured":"Cossu G, Daniel RT, Messerer M (2016) Gangliocytomas of the sellar region: A challenging diagnosis. Clin Neurol Neurosurg 149: 122\u2013135. S0303\u20138467(16)30286\u20134.\u00a0https:\/\/doi.org\/10.1016\/j.clineuro.2016.08.002","DOI":"10.1016\/j.clineuro.2016.08.002"},{"key":"9703_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-0029-1211342","volume":"103","author":"MJA Puchner","year":"1995","unstructured":"Puchner MJA, L\u00fcdecke DK, Saeger W, Riedel M, Asa SL (1995) Gangliocytomas of the sellar region - a review. Exper Clin Endocrinol 103: 129-149.","journal-title":"Exper Clin Endocrinol"},{"key":"9703_CR59","doi-asserted-by":"publisher","unstructured":"Asa SL, Mete O (2019) Hypothalamic Endocrine Tumors: An Update. J Clin Med 8.\u00a0https:\/\/doi.org\/10.3390\/jcm8101741","DOI":"10.3390\/jcm8101741"},{"key":"9703_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAS.0000000000001185","volume":"42","author":"SL Asa","year":"2018","unstructured":"Asa SL, Ezzat S, Kelly DF, Cohan P, Takasumi Y, Barkhoudarian G, Heaney AP, Ridout R, Chik CL, Thompson LDR, Gentili F, Mete O (2018) Hypothalamic Vasopressin-producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease. Am J Surg Pathol 42: 251-260. https:\/\/doi.org\/10.1097\/PAS.0000000000001185","journal-title":"Am J Surg Pathol"},{"key":"9703_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117107","volume":"10","author":"J Denes","year":"2015","unstructured":"Denes J, Kasuki L, Trivellin G, Colli LM, Takiya CM, Stiles CE, Barry S, de CM, Gadelha MR, Korbonits M (2015) Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. PLoS ONE 10: e0117107. https:\/\/doi.org\/10.1371\/journal.pone.0117107","journal-title":"PLoS ONE"},{"key":"9703_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09644-z","author":"N Fukuhara","year":"2020","unstructured":"Fukuhara N, Iwata T, Inoshita N, Yoshimoto K, Kitagawa M, Fukuhara H, Tatsushima K, Yamaguchi-Okada M, Takeshita A, Ito J, Takeuchi Y, Yamada S, Nishioka H (2020) Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma? Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-020-09644-z","journal-title":"Endocr Pathol"},{"key":"9703_CR63","doi-asserted-by":"publisher","unstructured":"Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, Cahill DP, Santagata S, Curry WT, Jr., Barker FG (2016) Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst 108. https:\/\/doi.org\/10.1093\/jnci\/djv310","DOI":"10.1093\/jnci\/djv310"},{"key":"9703_CR64","doi-asserted-by":"publisher","first-page":"640","DOI":"10.5858\/2010-0470-SAR1.1","volume":"135","author":"V Nose","year":"2011","unstructured":"Nose V, Ezzat S, Horvath E, Kovacs K, Laws ER, Lloyd R, Lopes MB, Asa SL (2011) Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med 135: 640-646.","journal-title":"Arch Pathol Lab Med"},{"key":"9703_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02655-0","author":"C Villa","year":"2019","unstructured":"Villa C, Vasiljevic A, Jaffrain-Rea ML, Ansorge O, Asioli S, Barresi V, Chinezu L, Gardiman MP, Lania A, Lapshina AM, Poliani L, Reiniger L, Righi A, Saeger W, Soukup J, Theodoropoulou M, Uccella S, Trouillas J, Roncaroli F (2019) A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch . https:\/\/doi.org\/10.1007\/s00428-019-02655-0","journal-title":"Virchows Arch"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09703-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:27:52Z","timestamp":1674952072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09703-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9703"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09703-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Ozgur Mete is the editor in chief of <i>Endocrine Pathology<\/i>. This article was handled by an independent senior editor and peer-reviewed as per the journal standards. Other authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}